The latest trading session saw Abbott (ABT) ending at $132.65, denoting a +1.4% adjustment from its last day's close. The stock exceeded the S&P 500, which registered a gain of 0.55% for the day.

"We are just at the beginning of a very exciting era," says Aerogen Director of R&D, Science and Emerging Technologies Ronan ...

Pentagon says Guam could be 1st target of Chinese missiles during Taiwan invasion ...

A chance discovery led a team of scientists from Rice University, University of Cambridge and Stanford University to ...

Abbott (NYSE: ABT) today announced data demonstrating substantial, sustained improvements with its TriClip system.

All malaria rapid diagnostic tests have been implicated in the WHO product alert, as manufacturer investigations continue.

Abbott today announced late-breaking data from its TRILUMINATEtm Pivotal trial that show the TriCliptm transcatheter edge-to-edge repair (TEER) system to treat tricuspid regurgitation (TR), or a leaky ...

Abbott (ABT) announced late-breaking data from its Triluminate Pivotal trial that show the TriClip transcatheter edge-to-edge repair system to ...

Abbott (NYSE: ABT) today announced late-breaking data from its TRILUMINATE™ Pivotal trial that show the TriClip™ transcatheter edge-to-edge repair (TEER) system to treat tricuspid regurgitation (TR), ...

Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has ...

For any parent, the arrival of a new baby is joyful. But for a Hanover, Minnesota, family, a prenatal checkup turned into ...

It's never a good thing, when a bacterial biofilm forms on the surface of a medical implant. There could soon be a new way of ...